Barclays PLC Raises Stake in CureVac (NASDAQ:CVAC)
Barclays PLC raised its stake in CureVac (NASDAQ:CVAC – Free Report) by 51.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 34,836 shares of the company’s stock after acquiring an additional 11,890 shares during the quarter. Barclays PLC’s holdings in CureVac were […]
Barclays PLC raised its stake in CureVac (NASDAQ:CVAC – Free Report) by 51.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 34,836 shares of the company’s stock after acquiring an additional 11,890 shares during the quarter. Barclays PLC’s holdings in CureVac were […]
